Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 112-116

  Nappi, R E ^a,b   Albani, F ^b   Chiovato, L ^b   Polatti, F ^a  

^a Research Center for Reproductive Medicine   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Health Status; Heart Disease; Hypertension; Lubrication; Satisfaction; Sexual Problems; Urogenital Atrophy; Vaginal Route

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN;

ARTICLE; CARDIOVASCULAR DISEASE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; ESTROGEN THERAPY; FEMALE SEXUAL DYSFUNCTION; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; POSTMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUAL COUNSELING; SEXUAL FUNCTION; SEXUALITY; VAGINA ATROPHY; VAGINAL DRYNESS; VAGINITIS; ATROPHY; DRUG EFFECT; FEMALE; FEMALE GENITAL SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; UROGENITAL TRACT DISEASE;

ATROPHY; CARDIOVASCULAR DISEASES; ESTROGENS; FEMALE; FEMALE UROGENITAL DISEASES; GENITALIA, FEMALE; HEALTH STATUS; HUMANS; POSTMENOPAUSE; QUALITY OF LIFE; SEX COUNSELING; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 73949141227     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130903010482     Document Type: Article

References (23)

1. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004;11:120-30 (Pubitemid 40362209)
2. Nappi RE, Polatti F. The use of estrogen therapy in women's sexual functioning. J Sex Med 2009;6:603-16
3. Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004;49:292-303 (Pubitemid 39505183)
4. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-74 (Pubitemid 47295643)
5. Nappi RE. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 2007;10(Suppl 2):105-8 (Pubitemid 47450847)
6. Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15:661-6
7. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;77:S42-8 (Pubitemid 34465843)
8. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008;112:970-8
9. Manolis A, Doumas M. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-oflife complications. J Hypertens 2008;26:2074-84
10. McCall-Hosenfeld JS, Freund KM, Legault C, et al. Sexual satisfaction and cardiovascular disease: the Women's Health Initiative. Am J Med 2008;121:295-301 (Pubitemid 351417837)
11. Munarriz R, Kim NN, Goldstein I, Traish AM. Biology of female sexual function. Urol Clin North Am 2002;29:685-93 (Pubitemid 35417180)
12. Addis IB, Ireland CC, Vittinghoff E, Lin F, Stuenkel CA, Hulley S. Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol 2005;106:121-7 (Pubitemid 40898443)
13. Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Julia MD. Management of postmenopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005;52:S46-52 (Pubitemid 41630619)
14. Long CY, Liu CM, Hsu SC, Wu CH, Wang CL, Tsai EM. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006;13:737-43
15. Al-Baghdadi O, Ewies AA. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 2009;12:91-105
16. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;4:CD001500
17. Kendall A, Dowsett M, Folkerd E, Smith I. Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584-7
18. Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7:156-61 (Pubitemid 30249896)
19. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293-7 (Pubitemid 30156501)
20. Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obstet Gynecol 2008;112:1053-60
21. Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67-76
22. Weisberg E, Ayton R, Darling G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005;8:83-92 (Pubitemid 40675125)
23. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355-69